Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms: GRGDS

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 2 mg | $48 | Inquiry | Inquiry | |
| 5 mg | $85 | Inquiry | Inquiry | |
| 10 mg | $135 | Inquiry | Inquiry | |
| 25 mg | $216 | Inquiry | Inquiry |
| Description | Gly-Arg-Gly-Asp-Ser (GRGDS) is a synthetic pentapeptide derived from the cell-binding region of fibronectin. Its core Arg-Gly-Asp (RGD) sequence is the key structure that mediates cell adhesion activity. Gly-Arg-Gly-Asp-Ser also possesses the function of inhibiting angiotensin-converting enzyme (ACE) activity. |
| Targets & IC50 | αvβ5 integrin:6.5 μM, αvβ3 integrin:5 μM |
| In vitro | Method: Human osteoblast-like MG-63 cells were seeded onto TiO₂ nanotube surfaces immobilized with Gly-Arg-Gly-Asp-Ser peptide (GRGDS concentration: 0.2 mg/mL, immobilized via chemical grafting). Cell viability was assessed using the XTT assay after 2 and 4 days of culture, while the level of cell differentiation was evaluated by ALP activity assay after 4 and 7 days of culture. Results: Compared with the control group (plain TiO₂ nanotubes), the Gly-Arg-Gly-Asp-Ser-immobilized group significantly promoted MG-63 cell proliferation after 4 days of culture (p < 0.05). After 2 hours of culture, cells appeared round; after 24 hours, cells in the Gly-Arg-Gly-Asp-Ser-immobilized group exhibited more extensive spreading and a greater number of filopodia. However, no significant difference in ALP activity was observed between the two groups after 4 and 7 days of culture [1]. |
| Synonyms | GRGDS |
| Molecular Weight | 490.47 |
| Formula | C17H30N8O9 |
| Cas No. | 96426-21-0 |
| Smiles | NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O |
| Relative Density. | 1.66 g/cm3 (Predicted) |
| Sequence | Gly-Arg-Gly-Asp-Ser |
| Sequence Short | GRGDS |
| Storage | Keep away from moisture, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 33.33 mg/mL (67.96 mM), Sonication is recommended. DMSO: 100 mg/mL (203.89 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (6.73 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | |||||||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.